Establishment of cell models for Blau syndrome
Objective To establish a stable and reliable cell models of Blau syndrome (BS)in vitro. Methods RAW264.7, iBMDM and THP-1 cells were used as the research objects and then stimulated by muramyl dipeptide (MDP) or L18-MDP. Meanwhile, positive drugs etanercept (ETN) and GSK583 treatment groups were set...
Main Author: | SONG Hao-xin, YE Cai-ying, ZHU Lei |
---|---|
Format: | Article |
Language: | zho |
Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2022-03-01
|
Series: | Jichu yixue yu linchuang |
Subjects: | |
Online Access: | http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-3-406.pdf |
Similar Items
-
Effect of muramyl dipeptide and alum adjuvants on immunization with Filarial multi antigen peptide vaccine in mice model
by: Christiana I., et al.
Published: (2016-09-01) -
Advances in research of Blau syndrome
by: KOU Yu-hui, YE Cai-ying, XING Cheng-feng
Published: (2022-12-01) -
A Case Report of Blau Syndrome
by: LI Guozhuang, et al.
Published: (2023-10-01) -
Blau syndrome: a case report from Palestine
by: Salam Iriqat, et al.
Published: (2021-08-01) -
Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
by: Eliza Iwicka, et al.
Published: (2022-09-01)